Global Rare Disease Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Rare Disease Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Rare Disease Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Rare Disease Drug by Country/Region, 2017, 2022 & 2028

2.2 Rare Disease Drug Segment by Type

2.2.1 Above 1‰

2.2.2 0.65‰～1‰

2.2.3 Below 0.1‰

2.3 Rare Disease Drug Sales by Type

2.3.1 Global Rare Disease Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Rare Disease Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Rare Disease Drug Sale Price by Type (2017-2022)

2.4 Rare Disease Drug Segment by Application

2.4.1 Hospital Pharmacies

2.4.2 Speciality Pharmacies

2.4.3 Retail pharmacies

2.4.4 Others

2.5 Rare Disease Drug Sales by Application

2.5.1 Global Rare Disease Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Rare Disease Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Rare Disease Drug Sale Price by Application (2017-2022)

3 Global Rare Disease Drug by Company

3.1 Global Rare Disease Drug Breakdown Data by Company

3.1.1 Global Rare Disease Drug Annual Sales by Company (2020-2022)

3.1.2 Global Rare Disease Drug Sales Market Share by Company (2020-2022)

3.2 Global Rare Disease Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Rare Disease Drug Revenue by Company (2020-2022)

3.2.2 Global Rare Disease Drug Revenue Market Share by Company (2020-2022)

3.3 Global Rare Disease Drug Sale Price by Company

3.4 Key Manufacturers Rare Disease Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Rare Disease Drug Product Location Distribution

3.4.2 Players Rare Disease Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Rare Disease Drug by Geographic Region

4.1 World Historic Rare Disease Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Rare Disease Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Rare Disease Drug Annual Revenue by Geographic Region

4.2 World Historic Rare Disease Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Rare Disease Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Rare Disease Drug Annual Revenue by Country/Region

4.3 Americas Rare Disease Drug Sales Growth

4.4 APAC Rare Disease Drug Sales Growth

4.5 Europe Rare Disease Drug Sales Growth

4.6 Middle East & Africa Rare Disease Drug Sales Growth

5 Americas

5.1 Americas Rare Disease Drug Sales by Country

5.1.1 Americas Rare Disease Drug Sales by Country (2017-2022)

5.1.2 Americas Rare Disease Drug Revenue by Country (2017-2022)

5.2 Americas Rare Disease Drug Sales by Type

5.3 Americas Rare Disease Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Rare Disease Drug Sales by Region

6.1.1 APAC Rare Disease Drug Sales by Region (2017-2022)

6.1.2 APAC Rare Disease Drug Revenue by Region (2017-2022)

6.2 APAC Rare Disease Drug Sales by Type

6.3 APAC Rare Disease Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Rare Disease Drug by Country

7.1.1 Europe Rare Disease Drug Sales by Country (2017-2022)

7.1.2 Europe Rare Disease Drug Revenue by Country (2017-2022)

7.2 Europe Rare Disease Drug Sales by Type

7.3 Europe Rare Disease Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Rare Disease Drug by Country

8.1.1 Middle East & Africa Rare Disease Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Rare Disease Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Rare Disease Drug Sales by Type

8.3 Middle East & Africa Rare Disease Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Rare Disease Drug

10.3 Manufacturing Process Analysis of Rare Disease Drug

10.4 Industry Chain Structure of Rare Disease Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Rare Disease Drug Distributors

11.3 Rare Disease Drug Customer

12 World Forecast Review for Rare Disease Drug by Geographic Region

12.1 Global Rare Disease Drug Market Size Forecast by Region

12.1.1 Global Rare Disease Drug Forecast by Region (2023-2028)

12.1.2 Global Rare Disease Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Rare Disease Drug Forecast by Type

12.7 Global Rare Disease Drug Forecast by Application

13 Key Players Analysis

13.1 Novartis AG

13.1.1 Novartis AG Company Information

13.1.2 Novartis AG Rare Disease Drug Product Offered

13.1.3 Novartis AG Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Novartis AG Main Business Overview

13.1.5 Novartis AG Latest Developments

13.2 Bristol-Myers Squibb Company

13.2.1 Bristol-Myers Squibb Company Company Information

13.2.2 Bristol-Myers Squibb Company Rare Disease Drug Product Offered

13.2.3 Bristol-Myers Squibb Company Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bristol-Myers Squibb Company Main Business Overview

13.2.5 Bristol-Myers Squibb Company Latest Developments

13.3 Celgene Corporation

13.3.1 Celgene Corporation Company Information

13.3.2 Celgene Corporation Rare Disease Drug Product Offered

13.3.3 Celgene Corporation Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Celgene Corporation Main Business Overview

13.3.5 Celgene Corporation Latest Developments

13.4 F. Hoffmann-La Roche Ltd.

13.4.1 F. Hoffmann-La Roche Ltd. Company Information

13.4.2 F. Hoffmann-La Roche Ltd. Rare Disease Drug Product Offered

13.4.3 F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 F. Hoffmann-La Roche Ltd. Main Business Overview

13.4.5 F. Hoffmann-La Roche Ltd. Latest Developments

13.5 Pfizer, Inc.

13.5.1 Pfizer, Inc. Company Information

13.5.2 Pfizer, Inc. Rare Disease Drug Product Offered

13.5.3 Pfizer, Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Pfizer, Inc. Main Business Overview

13.5.5 Pfizer, Inc. Latest Developments

13.6 Sanofi S.A.

13.6.1 Sanofi S.A. Company Information

13.6.2 Sanofi S.A. Rare Disease Drug Product Offered

13.6.3 Sanofi S.A. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sanofi S.A. Main Business Overview

13.6.5 Sanofi S.A. Latest Developments

13.7 Alexion Pharmaceuticals, Inc.

13.7.1 Alexion Pharmaceuticals, Inc. Company Information

13.7.2 Alexion Pharmaceuticals, Inc. Rare Disease Drug Product Offered

13.7.3 Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Alexion Pharmaceuticals, Inc. Main Business Overview

13.7.5 Alexion Pharmaceuticals, Inc. Latest Developments

13.8 Eli Lilly and Company

13.8.1 Eli Lilly and Company Company Information

13.8.2 Eli Lilly and Company Rare Disease Drug Product Offered

13.8.3 Eli Lilly and Company Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Eli Lilly and Company Main Business Overview

13.8.5 Eli Lilly and Company Latest Developments

13.9 Novo Nordisk A/S

13.9.1 Novo Nordisk A/S Company Information

13.9.2 Novo Nordisk A/S Rare Disease Drug Product Offered

13.9.3 Novo Nordisk A/S Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Novo Nordisk A/S Main Business Overview

13.9.5 Novo Nordisk A/S Latest Developments

13.10 AstraZeneca

13.10.1 AstraZeneca Company Information

13.10.2 AstraZeneca Rare Disease Drug Product Offered

13.10.3 AstraZeneca Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 AstraZeneca Main Business Overview

13.10.5 AstraZeneca Latest Developments

13.11 Eisai Co., Ltd.

13.11.1 Eisai Co., Ltd. Company Information

13.11.2 Eisai Co., Ltd. Rare Disease Drug Product Offered

13.11.3 Eisai Co., Ltd. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Eisai Co., Ltd. Main Business Overview

13.11.5 Eisai Co., Ltd. Latest Developments

13.12 Daiichi Sankyo Company Limited

13.12.1 Daiichi Sankyo Company Limited Company Information

13.12.2 Daiichi Sankyo Company Limited Rare Disease Drug Product Offered

13.12.3 Daiichi Sankyo Company Limited Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Daiichi Sankyo Company Limited Main Business Overview

13.12.5 Daiichi Sankyo Company Limited Latest Developments

13.13 Bayer AG

13.13.1 Bayer AG Company Information

13.13.2 Bayer AG Rare Disease Drug Product Offered

13.13.3 Bayer AG Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Bayer AG Main Business Overview

13.13.5 Bayer AG Latest Developments

13.14 GlaxoSmithKline

13.14.1 GlaxoSmithKline Company Information

13.14.2 GlaxoSmithKline Rare Disease Drug Product Offered

13.14.3 GlaxoSmithKline Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 GlaxoSmithKline Main Business Overview

13.14.5 GlaxoSmithKline Latest Developments

13.15 Merck & Co., Inc.

13.15.1 Merck & Co., Inc. Company Information

13.15.2 Merck & Co., Inc. Rare Disease Drug Product Offered

13.15.3 Merck & Co., Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Merck & Co., Inc. Main Business Overview

13.15.5 Merck & Co., Inc. Latest Developments

13.16 Johnson & Johnson

13.16.1 Johnson & Johnson Company Information

13.16.2 Johnson & Johnson Rare Disease Drug Product Offered

13.16.3 Johnson & Johnson Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Johnson & Johnson Main Business Overview

13.16.5 Johnson & Johnson Latest Developments

13.17 Biogen, Inc.

13.17.1 Biogen, Inc. Company Information

13.17.2 Biogen, Inc. Rare Disease Drug Product Offered

13.17.3 Biogen, Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Biogen, Inc. Main Business Overview

13.17.5 Biogen, Inc. Latest Developments

13.18 Takeda

13.18.1 Takeda Company Information

13.18.2 Takeda Rare Disease Drug Product Offered

13.18.3 Takeda Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Takeda Main Business Overview

13.18.5 Takeda Latest Developments

13.19 Amgen, Inc.

13.19.1 Amgen, Inc. Company Information

13.19.2 Amgen, Inc. Rare Disease Drug Product Offered

13.19.3 Amgen, Inc. Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Amgen, Inc. Main Business Overview

13.19.5 Amgen, Inc. Latest Developments

13.20 Deciphera

13.20.1 Deciphera Company Information

13.20.2 Deciphera Rare Disease Drug Product Offered

13.20.3 Deciphera Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Deciphera Main Business Overview

13.20.5 Deciphera Latest Developments

13.21 Atara Biotherapeutics

13.21.1 Atara Biotherapeutics Company Information

13.21.2 Atara Biotherapeutics Rare Disease Drug Product Offered

13.21.3 Atara Biotherapeutics Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Atara Biotherapeutics Main Business Overview

13.21.5 Atara Biotherapeutics Latest Developments

13.22 ProQR

13.22.1 ProQR Company Information

13.22.2 ProQR Rare Disease Drug Product Offered

13.22.3 ProQR Rare Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 ProQR Main Business Overview

13.22.5 ProQR Latest Developments

14 Research Findings and Conclusion

Table 1. Rare Disease Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Rare Disease Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Above 1‰

Table 4. Major Players of 0.65‰～1‰

Table 5. Major Players of Below 0.1‰

Table 6. Global Rare Disease Drug Sales by Type (2017-2022) & (K Doses)

Table 7. Global Rare Disease Drug Sales Market Share by Type (2017-2022)

Table 8. Global Rare Disease Drug Revenue by Type (2017-2022) & ($ million)

Table 9. Global Rare Disease Drug Revenue Market Share by Type (2017-2022)

Table 10. Global Rare Disease Drug Sale Price by Type (2017-2022) & (USD/Dose)

Table 11. Global Rare Disease Drug Sales by Application (2017-2022) & (K Doses)

Table 12. Global Rare Disease Drug Sales Market Share by Application (2017-2022)

Table 13. Global Rare Disease Drug Revenue by Application (2017-2022)

Table 14. Global Rare Disease Drug Revenue Market Share by Application (2017-2022)

Table 15. Global Rare Disease Drug Sale Price by Application (2017-2022) & (USD/Dose)

Table 16. Global Rare Disease Drug Sales by Company (2020-2022) & (K Doses)

Table 17. Global Rare Disease Drug Sales Market Share by Company (2020-2022)

Table 18. Global Rare Disease Drug Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Rare Disease Drug Revenue Market Share by Company (2020-2022)

Table 20. Global Rare Disease Drug Sale Price by Company (2020-2022) & (USD/Dose)

Table 21. Key Manufacturers Rare Disease Drug Producing Area Distribution and Sales Area

Table 22. Players Rare Disease Drug Products Offered

Table 23. Rare Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Rare Disease Drug Sales by Geographic Region (2017-2022) & (K Doses)

Table 27. Global Rare Disease Drug Sales Market Share Geographic Region (2017-2022)

Table 28. Global Rare Disease Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Rare Disease Drug Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Rare Disease Drug Sales by Country/Region (2017-2022) & (K Doses)

Table 31. Global Rare Disease Drug Sales Market Share by Country/Region (2017-2022)

Table 32. Global Rare Disease Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Rare Disease Drug Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Rare Disease Drug Sales by Country (2017-2022) & (K Doses)

Table 35. Americas Rare Disease Drug Sales Market Share by Country (2017-2022)

Table 36. Americas Rare Disease Drug Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Rare Disease Drug Revenue Market Share by Country (2017-2022)

Table 38. Americas Rare Disease Drug Sales by Type (2017-2022) & (K Doses)

Table 39. Americas Rare Disease Drug Sales Market Share by Type (2017-2022)

Table 40. Americas Rare Disease Drug Sales by Application (2017-2022) & (K Doses)

Table 41. Americas Rare Disease Drug Sales Market Share by Application (2017-2022)

Table 42. APAC Rare Disease Drug Sales by Region (2017-2022) & (K Doses)

Table 43. APAC Rare Disease Drug Sales Market Share by Region (2017-2022)

Table 44. APAC Rare Disease Drug Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Rare Disease Drug Revenue Market Share by Region (2017-2022)

Table 46. APAC Rare Disease Drug Sales by Type (2017-2022) & (K Doses)

Table 47. APAC Rare Disease Drug Sales Market Share by Type (2017-2022)

Table 48. APAC Rare Disease Drug Sales by Application (2017-2022) & (K Doses)

Table 49. APAC Rare Disease Drug Sales Market Share by Application (2017-2022)

Table 50. Europe Rare Disease Drug Sales by Country (2017-2022) & (K Doses)

Table 51. Europe Rare Disease Drug Sales Market Share by Country (2017-2022)

Table 52. Europe Rare Disease Drug Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Rare Disease Drug Revenue Market Share by Country (2017-2022)

Table 54. Europe Rare Disease Drug Sales by Type (2017-2022) & (K Doses)

Table 55. Europe Rare Disease Drug Sales Market Share by Type (2017-2022)

Table 56. Europe Rare Disease Drug Sales by Application (2017-2022) & (K Doses)

Table 57. Europe Rare Disease Drug Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Rare Disease Drug Sales by Country (2017-2022) & (K Doses)

Table 59. Middle East & Africa Rare Disease Drug Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Rare Disease Drug Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Rare Disease Drug Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Rare Disease Drug Sales by Type (2017-2022) & (K Doses)

Table 63. Middle East & Africa Rare Disease Drug Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Rare Disease Drug Sales by Application (2017-2022) & (K Doses)

Table 65. Middle East & Africa Rare Disease Drug Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Rare Disease Drug

Table 67. Key Market Challenges & Risks of Rare Disease Drug

Table 68. Key Industry Trends of Rare Disease Drug

Table 69. Rare Disease Drug Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Rare Disease Drug Distributors List

Table 72. Rare Disease Drug Customer List

Table 73. Global Rare Disease Drug Sales Forecast by Region (2023-2028) & (K Doses)

Table 74. Global Rare Disease Drug Sales Market Forecast by Region

Table 75. Global Rare Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Rare Disease Drug Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Rare Disease Drug Sales Forecast by Country (2023-2028) & (K Doses)

Table 78. Americas Rare Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Rare Disease Drug Sales Forecast by Region (2023-2028) & (K Doses)

Table 80. APAC Rare Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Rare Disease Drug Sales Forecast by Country (2023-2028) & (K Doses)

Table 82. Europe Rare Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Rare Disease Drug Sales Forecast by Country (2023-2028) & (K Doses)

Table 84. Middle East & Africa Rare Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Rare Disease Drug Sales Forecast by Type (2023-2028) & (K Doses)

Table 86. Global Rare Disease Drug Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Rare Disease Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Rare Disease Drug Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Rare Disease Drug Sales Forecast by Application (2023-2028) & (K Doses)

Table 90. Global Rare Disease Drug Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Rare Disease Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Rare Disease Drug Revenue Market Share Forecast by Application (2023-2028)

Table 93. Novartis AG Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 94. Novartis AG Rare Disease Drug Product Offered

Table 95. Novartis AG Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 96. Novartis AG Main Business

Table 97. Novartis AG Latest Developments

Table 98. Bristol-Myers Squibb Company Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 99. Bristol-Myers Squibb Company Rare Disease Drug Product Offered

Table 100. Bristol-Myers Squibb Company Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 101. Bristol-Myers Squibb Company Main Business

Table 102. Bristol-Myers Squibb Company Latest Developments

Table 103. Celgene Corporation Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 104. Celgene Corporation Rare Disease Drug Product Offered

Table 105. Celgene Corporation Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 106. Celgene Corporation Main Business

Table 107. Celgene Corporation Latest Developments

Table 108. F. Hoffmann-La Roche Ltd. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 109. F. Hoffmann-La Roche Ltd. Rare Disease Drug Product Offered

Table 110. F. Hoffmann-La Roche Ltd. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 111. F. Hoffmann-La Roche Ltd. Main Business

Table 112. F. Hoffmann-La Roche Ltd. Latest Developments

Table 113. Pfizer, Inc. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 114. Pfizer, Inc. Rare Disease Drug Product Offered

Table 115. Pfizer, Inc. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 116. Pfizer, Inc. Main Business

Table 117. Pfizer, Inc. Latest Developments

Table 118. Sanofi S.A. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 119. Sanofi S.A. Rare Disease Drug Product Offered

Table 120. Sanofi S.A. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 121. Sanofi S.A. Main Business

Table 122. Sanofi S.A. Latest Developments

Table 123. Alexion Pharmaceuticals, Inc. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 124. Alexion Pharmaceuticals, Inc. Rare Disease Drug Product Offered

Table 125. Alexion Pharmaceuticals, Inc. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 126. Alexion Pharmaceuticals, Inc. Main Business

Table 127. Alexion Pharmaceuticals, Inc. Latest Developments

Table 128. Eli Lilly and Company Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 129. Eli Lilly and Company Rare Disease Drug Product Offered

Table 130. Eli Lilly and Company Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 131. Eli Lilly and Company Main Business

Table 132. Eli Lilly and Company Latest Developments

Table 133. Novo Nordisk A/S Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 134. Novo Nordisk A/S Rare Disease Drug Product Offered

Table 135. Novo Nordisk A/S Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 136. Novo Nordisk A/S Main Business

Table 137. Novo Nordisk A/S Latest Developments

Table 138. AstraZeneca Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 139. AstraZeneca Rare Disease Drug Product Offered

Table 140. AstraZeneca Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 141. AstraZeneca Main Business

Table 142. AstraZeneca Latest Developments

Table 143. Eisai Co., Ltd. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 144. Eisai Co., Ltd. Rare Disease Drug Product Offered

Table 145. Eisai Co., Ltd. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 146. Eisai Co., Ltd. Main Business

Table 147. Eisai Co., Ltd. Latest Developments

Table 148. Daiichi Sankyo Company Limited Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 149. Daiichi Sankyo Company Limited Rare Disease Drug Product Offered

Table 150. Daiichi Sankyo Company Limited Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 151. Daiichi Sankyo Company Limited Main Business

Table 152. Daiichi Sankyo Company Limited Latest Developments

Table 153. Bayer AG Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 154. Bayer AG Rare Disease Drug Product Offered

Table 155. Bayer AG Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 156. Bayer AG Main Business

Table 157. Bayer AG Latest Developments

Table 158. GlaxoSmithKline Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 159. GlaxoSmithKline Rare Disease Drug Product Offered

Table 160. GlaxoSmithKline Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 161. GlaxoSmithKline Main Business

Table 162. GlaxoSmithKline Latest Developments

Table 163. Merck & Co., Inc. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 164. Merck & Co., Inc. Rare Disease Drug Product Offered

Table 165. Merck & Co., Inc. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 166. Merck & Co., Inc. Main Business

Table 167. Merck & Co., Inc. Latest Developments

Table 168. Johnson & Johnson Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 169. Johnson & Johnson Rare Disease Drug Product Offered

Table 170. Johnson & Johnson Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 171. Johnson & Johnson Main Business

Table 172. Johnson & Johnson Latest Developments

Table 173. Biogen, Inc. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 174. Biogen, Inc. Rare Disease Drug Product Offered

Table 175. Biogen, Inc. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 176. Biogen, Inc. Main Business

Table 177. Biogen, Inc. Latest Developments

Table 178. Takeda Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 179. Takeda Rare Disease Drug Product Offered

Table 180. Takeda Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 181. Takeda Main Business

Table 182. Takeda Latest Developments

Table 183. Amgen, Inc. Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 184. Amgen, Inc. Rare Disease Drug Product Offered

Table 185. Amgen, Inc. Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 186. Amgen, Inc. Main Business

Table 187. Amgen, Inc. Latest Developments

Table 188. Deciphera Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 189. Deciphera Rare Disease Drug Product Offered

Table 190. Deciphera Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 191. Deciphera Main Business

Table 192. Deciphera Latest Developments

Table 193. Atara Biotherapeutics Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 194. Atara Biotherapeutics Rare Disease Drug Product Offered

Table 195. Atara Biotherapeutics Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 196. Atara Biotherapeutics Main Business

Table 197. Atara Biotherapeutics Latest Developments

Table 198. ProQR Basic Information, Rare Disease Drug Manufacturing Base, Sales Area and Its Competitors

Table 199. ProQR Rare Disease Drug Product Offered

Table 200. ProQR Rare Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 201. ProQR Main Business

Table 202. ProQR Latest Developments

List of Figures

Figure 1. Picture of Rare Disease Drug

Figure 2. Rare Disease Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Rare Disease Drug Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Rare Disease Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Rare Disease Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Above 1‰

Figure 10. Product Picture of 0.65‰～1‰

Figure 11. Product Picture of Below 0.1‰

Figure 12. Global Rare Disease Drug Sales Market Share by Type in 2021

Figure 13. Global Rare Disease Drug Revenue Market Share by Type (2017-2022)

Figure 14. Rare Disease Drug Consumed in Hospital Pharmacies

Figure 15. Global Rare Disease Drug Market: Hospital Pharmacies (2017-2022) & (K Doses)

Figure 16. Rare Disease Drug Consumed in Speciality Pharmacies

Figure 17. Global Rare Disease Drug Market: Speciality Pharmacies (2017-2022) & (K Doses)

Figure 18. Rare Disease Drug Consumed in Retail pharmacies

Figure 19. Global Rare Disease Drug Market: Retail pharmacies (2017-2022) & (K Doses)

Figure 20. Rare Disease Drug Consumed in Others

Figure 21. Global Rare Disease Drug Market: Others (2017-2022) & (K Doses)

Figure 22. Global Rare Disease Drug Sales Market Share by Application (2017-2022)

Figure 23. Global Rare Disease Drug Revenue Market Share by Application in 2021

Figure 24. Rare Disease Drug Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Rare Disease Drug Revenue Market Share by Company in 2021

Figure 26. Global Rare Disease Drug Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Rare Disease Drug Revenue Market Share by Geographic Region in 2021

Figure 28. Global Rare Disease Drug Sales Market Share by Region (2017-2022)

Figure 29. Global Rare Disease Drug Revenue Market Share by Country/Region in 2021

Figure 30. Americas Rare Disease Drug Sales 2017-2022 (K Doses)

Figure 31. Americas Rare Disease Drug Revenue 2017-2022 ($ Millions)

Figure 32. APAC Rare Disease Drug Sales 2017-2022 (K Doses)

Figure 33. APAC Rare Disease Drug Revenue 2017-2022 ($ Millions)

Figure 34. Europe Rare Disease Drug Sales 2017-2022 (K Doses)

Figure 35. Europe Rare Disease Drug Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Rare Disease Drug Sales 2017-2022 (K Doses)

Figure 37. Middle East & Africa Rare Disease Drug Revenue 2017-2022 ($ Millions)

Figure 38. Americas Rare Disease Drug Sales Market Share by Country in 2021

Figure 39. Americas Rare Disease Drug Revenue Market Share by Country in 2021

Figure 40. United States Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Rare Disease Drug Sales Market Share by Region in 2021

Figure 45. APAC Rare Disease Drug Revenue Market Share by Regions in 2021

Figure 46. China Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Rare Disease Drug Sales Market Share by Country in 2021

Figure 53. Europe Rare Disease Drug Revenue Market Share by Country in 2021

Figure 54. Germany Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Rare Disease Drug Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Rare Disease Drug Revenue Market Share by Country in 2021

Figure 61. Egypt Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Rare Disease Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Rare Disease Drug in 2021

Figure 67. Manufacturing Process Analysis of Rare Disease Drug

Figure 68. Industry Chain Structure of Rare Disease Drug

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles